1. Pfizer to funnel $500M into biotechs — Bristol-Myers' Zeposia launches into crowded MS market — Merck CEO Frazier urges businesses to help bridge racial equity gap — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Abilify Mycite- 2 months and read now needs help selling

Discussion in 'Otsuka' started by anonymous, Sep 27, 2019 at 10:32 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Wow it only took 2 months to realize that Ready Now reps cannot sell Mycite and the red team is called to the rescue. Not surprising.
     

  2. anonymous

    anonymous Guest

    how much are we being paid to sell mycite?
     
  3. anonymous

    anonymous Guest

    Abilify MyCite is an asinine idea. If a SZ patient isn't compliant, just give him/her a long-acting injectable. D'uh.
     
  4. anonymous

    anonymous Guest

    ok so let me understand how freaking brilliant this is. A patient suffering with paranoid schizophrenia is told (or "asked") to take a drug that is tracked in their GI. hmmm brilliant!! Way to play into the paranoia! Does anyone see the insanity in this? Cheers to another brilliant marketing idea!
     
  5. anonymous

    anonymous Guest

    And our “leaders” congratulate themselves for being the geniuses they think they are. Only at Otsuka!
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    Proteus is on life support. Investors won't touch them. The really smart folks at Otsuka on the other hand pumped over $100M in this POS solution, which no one wants. I read a news release that says Otsuka will continue with Myciet and digital health. The definition of insanity is doing the same thing over and over again and expecting a different result. Time for Otsuka digital health team to take Abilify and wake up to reality.
     
  8. anonymous

    anonymous Guest

    I would not want to be at the home office in the department responsible for this mess. I am sure there is a lot of finger pointing going, people accusing each other for this mess. People didn't learn from the Ford Edsel.
     
  9. anonymous

    anonymous Guest

    from now on when things go really really bad, we can just say "I just Mycite'd"
     
  10. anonymous

    anonymous Guest

    Just because Otsuka thought this is a good idea, doesn’t mean everyone else thinks so too!
     
  11. anonymous

    anonymous Guest

    You have no idea. No longer with the company, but it is a cesspool of politics internally. The most underhanded of those responsible will come out of this in great shape (read: promotion, development opportunities, etc.)... the people who put their heads down and try to solve problems will get worked. Bet me.